Horn Howard — SEC Form 4 filings
SEC reporting owner CIK 1786335. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-05 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 12 filings — 59,941 shares, $1,797,988 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 7,465 shares @ $52.76 ($393,853) in Ultragenyx Pharmaceutical Inc., filed 2024-10-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer | 15 | — | 14 legs · 59,941 sh · $1,797,988 | 7 |
Form 4 filings — Horn Howard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 4,696 @ $24.92 | EDGAR |
| 2026-07-06 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 4,698 @ $33.13 | EDGAR |
| 2026-06-01 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 4,653 @ $23.77 | EDGAR |
| 2026-05-04 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 4,683 @ $24.90 | EDGAR |
| 2026-04-20 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 34,674 @ $0 · Grant/award (A): 59,952 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 4,683 @ $20.97 | EDGAR |
| 2026-03-03 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 6,143 @ $0 · Sale (S): 5,290 @ $22.80 · Sale (S): 3,119 @ $22.54 · Sale (S): 1,635 @ $22.40 | EDGAR |
| 2026-02-03 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 3,061 @ $23.56 | EDGAR |
| 2026-01-05 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 3,150 @ $22.84 | EDGAR |
| 2025-12-11 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 3,081 @ $36.38 | EDGAR |
| 2025-10-14 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 7,942 @ $31.51 | EDGAR |
| 2025-03-10 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 1,785 @ $40.40 | EDGAR |
| 2025-03-04 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 15,653 @ $0 · Grant/award (A): 28,160 (derivative) @ $0 | EDGAR |
| 2024-10-11 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 7,465 @ $52.76 | EDGAR |
| 2024-03-05 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 19,400 @ $0 · Grant/award (A): 34,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786335 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →